Objective
to report the 5-year clinical outcomes of TAVR compared to SAVR for the treatment of severe aortic stenosis
Study
multicentre, randomised study
Population
patients with severe aortic stenosis (self expanding CoreValve prosthesis)
Endpoints
composite of all-cause mortality, stroke, MI at 5 years
Conclusion
there are no significant differences in clinical adverse outcomes between TAVR and surgery for treatment of severe aortic stenosis at 5 years
Thyregod et al. Circulation. 2019;139:2714-23
